Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Skarke

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|January 25, 2003
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteersCarsten Skarke, Jutta Darimont, Helmut Schmidt, et al.
British Journal of Clinical Pharmacology|August 5, 2003
Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndromeCarsten Skarke, Helmut Schmidt, Gerd Geisslinger, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteersJörn Lötsch, Carsten Skarke, Helmut Schmidt, et al.
Pharmacogenomics|March 7, 2006
Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using PyrosequencingMaren Rohrbacher, Anja Kirchhof, Carsten Skarke, et al.
American Journal of Preventive Cardiology|March 28, 2025
Sleep disorders as risk factors for calcific aortic stenosisNadim El Jamal, Thomas G Brooks, Carsten Skarke, et al.
Anesthesiology|November 27, 2004
Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humansCarsten Skarke, Michael Langer, Marwan Jarrar, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose-Exposure Relationships to Define Clinical Development StrategiesSarapee Hirankarn, Jeffrey S Barrett, Naji Alamuddin, et al.
Pharmacogenomics|December 19, 2007
Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevanceCarsten Skarke, Patrick Schuss, Anja Kirchhof, et al.
Clinical Pharmacology and Therapeutics|October 10, 2003
Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidineCarsten Skarke, Marwan Jarrar, Katharina Erb, et al.
Pharmacogenetics|January 5, 2002
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphineJörn Lötsch, Carsten Skarke, Sabine Grösch, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|January 25, 2003
Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteersCarsten Skarke, Jutta Darimont, Helmut Schmidt, et al.
British Journal of Clinical Pharmacology|August 5, 2003
Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndromeCarsten Skarke, Helmut Schmidt, Gerd Geisslinger, et al.
Clinical Pharmacology and Therapeutics|August 22, 2002
Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteersJörn Lötsch, Carsten Skarke, Helmut Schmidt, et al.
Pharmacogenomics|March 7, 2006
Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using PyrosequencingMaren Rohrbacher, Anja Kirchhof, Carsten Skarke, et al.
American Journal of Preventive Cardiology|March 28, 2025
Sleep disorders as risk factors for calcific aortic stenosisNadim El Jamal, Thomas G Brooks, Carsten Skarke, et al.
Anesthesiology|November 27, 2004
Probenecid interacts with the pharmacokinetics of morphine-6-glucuronide in humansCarsten Skarke, Michael Langer, Marwan Jarrar, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose-Exposure Relationships to Define Clinical Development StrategiesSarapee Hirankarn, Jeffrey S Barrett, Naji Alamuddin, et al.
Pharmacogenomics|December 19, 2007
Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2) with reported clinical relevanceCarsten Skarke, Patrick Schuss, Anja Kirchhof, et al.
Clinical Pharmacology and Therapeutics|October 10, 2003
Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidineCarsten Skarke, Marwan Jarrar, Katharina Erb, et al.
Pharmacogenetics|January 5, 2002
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphineJörn Lötsch, Carsten Skarke, Sabine Grösch, et al.
Pageof 7